In Stock

Name: Daclatasvir
Brand name: NATDAC
Manufacturer: NATCO Pharma Limited, India
International Trademark: Daklinza™

Описание

Daclatasvir Natco (Natco) NatDac

Each tablet contains: Daclatasvir dihydrochloride. Daclatasvir is freely soluble in water. Daclatasvir is prescribed for the treatment of patients with chronic hepatitis C, together with Sofosbuvir tablets at a dosage of 400 mg. Daclatasvir revolutionizes the treatment of Hepatitis C with any genotype.

Pharmacological action

Daclatasvir is an inhibitor of non-structural proteins of the 5A molecule (NS5A), slows down the reproduction of the RNA virus. The advantage of Daclatasvir is that it is very effective against all genotypes, while Ledipasvir is mainly effective only against genotype 1. This is important because the most common form of hepatitis C is genotype 3. Daclatasvir Natdac has the shortest duration of treatment regardless of all genotypes, easy tolerability, high efficacy and is safe.

How to use Daclatasvir from Natco

The recommended dosage of Natdac is one tablet of the drug once a day during meals, every day at the same time.

It is recommended to take the drug together with the drug sofosbuvir for 3 months.

It is highly recommended to take the drug under strict medical supervision.

Side effects

  • dizziness
  • headache
  • fatigue
  • breathing problems
  • chest pain

Storage method

Store at a temperature of 15 ° C to 30 ° C in a dry place. Keep out of reach of children.

Daclatasvir Natco price

We deliver medicines to people with hepatitis C at low and competitive prices. We guarantee you the best quality of services.



    ×


      ×